ID
29110
Beschreibung
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Stichworte
Versionen (4)
- 22.02.18 22.02.18 -
- 24.02.18 24.02.18 -
- 25.02.18 25.02.18 -
- 17.09.21 17.09.21 -
Rechteinhaber
gsk
Hochgeladen am
25. Februar 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Ropinirole Case Report Form GSK RRL100013
Subject diary
Beschreibung
Subject Instructions
Beschreibung
Bring this diary and any unused study medication with you to your next clinic visit Enter the information in the diary every day as required Print neatly and legibly Use ink, preferably black, to complete the information in the diary If you make a mistake: Draw a single line through the incorrect entry and write the correct data nearby Do not "write over" or erase an incorrect entry Do not use correction materials, such as correction fluid or tape, on this diary Page 2 FINAL - 24 SEP 04 If you have questions or concerns, contact the study contact person listed on the front of the diary
Datentyp
text
Alias
- UMLS CUI [1,1]
- C3890583
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [1,3]
- C0034394
Beschreibung
Patient global improvement scale instrucitons
Datentyp
text
Alias
- UMLS CUI [1]
- C3639888
Beschreibung
You will take 2 doses of study medication every day. You should generally take your first dose 1 hour prior to when your RLS symptoms usually start. Your second dose should be taken at bedtime and at least 3 hours after the first dose. You should try to take your second dose within 6 hours of the first dose, as longer time frames between doses (e.g., 8 hours or more) may lead to the reoccurrence of RLS symptoms.
Datentyp
text
Beschreibung
Dosing information
Alias
- UMLS CUI-1
- C0678766
Beschreibung
Dosage given:___________ Tablet x ___________ mg
Datentyp
text
Alias
- UMLS CUI [1]
- C0178602
Beschreibung
Date and time of dosing
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
- UMLS CUI [1,4]
- C0040223
Beschreibung
dose administered by
Datentyp
text
Alias
- UMLS CUI [1]
- C2348343
Beschreibung
Dose checked and witnessed by
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0682356
- UMLS CUI [1,2]
- C1283174
- UMLS CUI [1,3]
- C0178602
Beschreibung
Comments
Datentyp
text
Alias
- UMLS CUI [1]
- C0947611
Beschreibung
Patient rated scale
Alias
- UMLS CUI-1
- C0681889
- UMLS CUI-2
- C1578483
Beschreibung
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0034394
- UMLS CUI [1,2]
- C0034380
- UMLS CUI [1,3]
- C0035258
Beschreibung
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datentyp
text
Alias
- UMLS CUI [1]
- C3640521
Beschreibung
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0349674
- UMLS CUI [1,2]
- C0037313
Beschreibung
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datentyp
text
Alias
- UMLS CUI [1]
- C3639722
Beschreibung
DOSING DETAILS
Alias
- UMLS CUI-1
- C0678766
Beschreibung
You will take 2 doses of study medication every day. You should generally take your first dose 1 hour prior to when your RLS symptoms usually start. Your second dose should be taken at bedtime and at least 3 hours after the first dose. You should try to take your second dose within 6 hours of the first dose, as longer time frames between doses (e.g., 8 hours or more) may lead to the reoccurrence of RLS symptoms
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1442085
- UMLS CUI [1,2]
- C0678766
Beschreibung
Dosage given:___________ Tablet x ___________ mg
Datentyp
text
Alias
- UMLS CUI [1]
- C0178602
Beschreibung
Date and time of dosing
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
- UMLS CUI [1,4]
- C0040223
Beschreibung
dose administered by
Datentyp
text
Alias
- UMLS CUI [1]
- C2348343
Beschreibung
Dose checked and witnessed by
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0682356
- UMLS CUI [1,2]
- C1283174
- UMLS CUI [1,3]
- C0178602
Beschreibung
Comments
Datentyp
text
Alias
- UMLS CUI [1]
- C0947611
Beschreibung
Actigraphy Information
Alias
- UMLS CUI-1
- C1171301
Beschreibung
(to be completed by study coordinator prior to giving diary to patient e.g. Monday, Tuesday)
Datentyp
date
Maßeinheiten
- Day Month Year
Alias
- UMLS CUI [1,1]
- C0677547
- UMLS CUI [1,2]
- C0240526
- UMLS CUI [1,3]
- C0442592
Beschreibung
Was the device with the "Right" label worn on Right leg Actigraphy Information
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1171301
- UMLS CUI [1,2]
- C0230442
Beschreibung
Was the device with the "Left" label worn on Left leg Actigraphy Information
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1171301
- UMLS CUI [1,2]
- C0230443
Beschreibung
AM or PM (circle one)
Datentyp
time
Alias
- UMLS CUI [1]
- C4289366
Beschreibung
____ AM or PM (circle one)
Datentyp
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C1170730
Ähnliche Modelle
Subject diary
C0040223 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0332189 (UMLS CUI [1,4])
C0035258 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C0001288 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C0392760 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037317 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0034394 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0034380 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037313 (UMLS CUI [1,2])
C0678766 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0240526 (UMLS CUI [1,2])
C0442592 (UMLS CUI [1,3])
C0230442 (UMLS CUI [1,2])
C0230443 (UMLS CUI [1,2])
C1170730 (UMLS CUI [1,2])